Q3 Pharma and Biotech Layoffs in Charts: More Than 1000 Each in July and August

Seeking Alpha10/05 02:02

12 Health Care Stocks Moving In Friday's After-Market Session

Benzinga09/28 04:31

Viracta Therapeutics Shares Are Trading Lower After Leerink Partners Downgraded the Stock From Outperform to Market Perform and Lowered Its Price Target From $5 to $3.

Benzinga08/16 23:28

RBC Adjusts Price Target on Viracta Therapeutics to $4 From $6, Maintains Outperform

MT Newswires08/15 20:47

ヴィラクタ セラピューティクス | 10-Q：Q2 2024 四半期報告書

SEC08/15 04:12

Viracta Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q2 EPS Results. Also, the Company Announced Its Phase 2 NAVAL-1 Trial Results and Will Begin a Randomized Controlled Trial (RCT).

Benzinga08/14 21:22